Cooperation on new cancer drug

Mogam Institute President Senyon Choe, right, poses with Y-Biologics CEO Park Young-woo, after signing an agreement at the institute in Yongin, Gyeonggi Province, Thursday, to jointly develop an immunotherapy treatment for cancer. Both parties agreed to cooperate in developing such drugs, which have fewer side effects, by taking advantage of Mogam’s pharmaceutical technology and anticancer substances discovered by Y-Biologics. Mogam is affiliated with Green Cross Corp., a leading vaccine and blood derivatives maker. Y-Biologics specializes in the development of antibody therapeutics. / Courtesy of Mogam Institute